Reduced striatal dopamine synthesis capacity in patients with schizophrenia during remission of positive symptoms.

MLA

Avram, Mihai, et al. “Reduced Striatal Dopamine Synthesis Capacity in Patients with Schizophrenia during Remission of Positive Symptoms.” Brain: A Journal of Neurology, vol. 142, no. 6, June 2019, pp. 1813–26. EBSCOhost, https://doi.org/10.1093/brain/awz093.

APA

Avram, M., Brandl, F., Cabello, J., Leucht, C., Scherr, M., Mustafa, M., Leucht, S., Ziegler, S., & Sorg, C. (2019). Reduced striatal dopamine synthesis capacity in patients with schizophrenia during remission of positive symptoms. Brain: A Journal of Neurology, 142(6), 1813–1826. https://doi.org/10.1093/brain/awz093

Chicago

Avram, Mihai, Felix Brandl, Jorge Cabello, Claudia Leucht, Martin Scherr, Mona Mustafa, Stefan Leucht, Sibylle Ziegler, and Christian Sorg. 2019. “Reduced Striatal Dopamine Synthesis Capacity in Patients with Schizophrenia during Remission of Positive Symptoms.” Brain: A Journal of Neurology 142 (6): 1813–26. doi:10.1093/brain/awz093.